We hypothesized that mental illness symptoms and unhealthy substance use would be associated with non‐nucleoside reverse transcriptase inhibitor (NNRTI)‐based ART (still commonly used in LMICs), lower CD4 count, detectable viral load, comorbid NCDs and coinfections in our cohort. Here, CD4 is linked to psychiatric disorder.